Factor VIIa-tissue factor: Functional importance of protein-membrane interactions

Thrombosis and Haemostasis

Volumn 78, Issue 1, 1997, Pages 112-116

  Morrissey, James H ^a   Neuenschwander, Pierre F ^b   Huang, Qiuling ^b   McCallum, Christine D ^b   Su, Bixia ^b   Johnson, Arthur E ^b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; MEMBRANE PHOSPHOLIPID; MEMBRANE PROTEIN; PROTEINASE; THROMBOPLASTIN;

BLOOD CLOTTING; CONFERENCE PAPER; ENZYME SUBSTRATE; ENZYME SUBUNIT; HEMOSTASIS; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; THROMBOSIS;

EID: 0030745169     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1657511     Document Type: Conference Paper

References (47)

1. Banner DW, D'Arcy A, Chène C, Winkler FK, Guha A, Konigsberg WH, Nemerson Y, Kirchhofer D. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor. Nature 1996; 380:41-46.
2. Carson SD, Brozna JP. The role of tissue factor in the production of thrombin. Blood Coag Fibrinol 1993; 4:281-292.
3. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134:1087-1097.
4. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res 1990; 57:765-781.
5. 2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation Factor X by activated Factor VII. Biochem J 1990; 265:327-336.
6. Komiyama Y, Pedersen AH, Kisiel W. Proteolytic activation of human factors IX and X by recombinant human factor VIIa: Effects of calcium, phospholipids, and tissue factor. Biochemistry 1990; 29:9418-9425.
7. Muller YA, Ultsch MH, Kelley RF, De Vos AM. Structure of the extracellular domain of human tissue factor: Location of the factor VIIa binding site. Biochemistry 1994; 33:10864-10870.
8. Harlos K, Martin DMA, O'Brien DP, Jones EY, Stuart DI, Polikarpov I, Miller A, Tuddenham EGD, Boys CWG. Crystal structure of the extracellular region of human tissue factor. Nature 1994; 370:662-666.
9. Paborsky LR, Caras IW, Fisher KL, Gorman CM. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 1991; 266:21911-21916.
10. Ruf W, Rehemtulla A, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991; 266:2158-2166.
11. Shigematsu Y, Miyata T, Higashi S, Miki T, Sadler JE, Iwanaga S. Expression of human soluble tissue factor in yeast and enzymatic properties of its complex with factor VIIa. J Biol Chem 1992; 267:21329-21337.
12. Waxman E, Ross JBA, Laue TM, Guha A, Thiruvikraman SV, Lin TC, Konigsberg WH, Nemerson Y. Tissue factor and its extracellular soluble domain: The relationship between intermolecular association with factor Vila and enzymatic activity of the complex. Biochemistry 1992; 31:3998-4003.
13. Rezaie AR, Fiore MM, Neuenschwander PF, Esmon CT, Morrissey JH. Expression and purification of a soluble tissue factor fusion protein with an epitope for an unusual calcium-dependent antibody. Protein Express Purif 1992; 3:453-460.
14. Waxman E, Laws WR, Laue TM, Nemerson Y, Ross JBA. Human factor VIIa and its complex with soluble tissue factor: Evaluation of asymmetry and conformational dynamics by ultracentrifugation and fluorescence anisotropy decay methods. Biochemistry 1993; 32:3005-3012.
15. Neuenschwander PF, Morrissey JH. Deletion of the membrane anchoring region of tissue factor abolishes autoactivation of factor VII but not cofactor function. Analysis of a mutant with a selective deficiency in activity. J Biol Chem 1992; 267:14477-14482.
16. Neuenschwander PF, Morrissey JH. Roles of the membrane-interactive regions of factor VIIa and tissue factor. The factor VIIa G1a domain is dispensable for binding to tissue factor but important for activation of factor X. J Biol Chem 1994; 269:8007-8013.
17. Hagen FS, Gray CL, O'Hara P, Grant FJ, Saari GC, Woodbury RG, Hart CE, Insley M, Kisiel W, Kurachi K, Davie EW. Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci USA 1986; 83:2412-2416.
18. Wildgoose P, Jorgensen T, Komiyama Y, Nakagaki T, Pedersen A, Kisiel W. The role of phospholipids and the factor VII G1a-domain in the interaction of factor VII with tissue factor. Thromb Haemost 1992; 67:679-685.
19. 2+ binding sites in the gamma-carboxyglutamic acid-containing domain of factor VIIa. Eur J Biochem 1995; 234:293-300.
20. 2+ ion binding sites in factor VIIa and in des(1-38) factor VIIa. FEBS Lett 1992; 306:265-268.
21. Wildgoose P, Foster D, Schiodt J, Wiberg FC, Birktoft JJ, Petersen LC. Identification of a calcium binding site in the protease domain of human blood coagulation factor VII: Evidence for its role in factor VII-tissue factor interaction. Biochemistry 1993; 32:114-119.
22. 2+ and tissue factor studied using circular dichroism spectroscopy. Protein Sci 1996; 5:1531-1540.
23. McCallum CD, Hapak RC, Neuenschwander PF, Morrissey JH, Johnson AE. The location of the active site of blood coagulation factor VIIa above the membrane surface and its reorientation upon association with tissue factor - A fluorescence energy transfer study. J Biol Chem 1996; 271:28168-28175.
24. Husten EJ, Esmon CT, Johnson AE. The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex. J Biol Chem 1987; 26212953-12961.
25. Nemerson Y. The phospholipid requirement of tissue factor in blood coagulation. J Clin Invest 1968; 47:72-80.
26. Liu DTH, McCoy LE. Phospholipid requirement of tissue thromboplastin in blood coagulation. Thromb Res 1975; 7:213-221.
27. Rouser G, White S, Schloredt D. Phospholipid structure and thromboplastic activity. I. The phosphatide fraction active in recalcified normal human plasma. Biochim Biophys Acta 1950; 28:71-80.
28. Rouser G. Phospholipid structure and thromboplastic activity. II. The fatty acid composition of the active phosphatidyl ethanolamines. Biochim Biophys Acta 1958; 28:81-87.
29. Wallach DFH, Maurice PA, Steele BB, Surgenor DM. Studies on the relationship between the colloidal state and clot-promoting activity of pure phosphatidylethanolamines. J Biol Chem 1959; 234:2829-2834.
30. Nemerson Y. Characteristics and lipid requirements of coagulant proteins extracted from lung and brain: The specificity of the protein component of tissue factor. J Clin Invest 1969; 48:322-331.
31. Cutsforth GA, Whitaker RN, Hermans J, Lentz BR. A new model to describe extrinsic protein binding to phospholipid membranes of varying composition: Application to human coagulation proteins. Biochemistry 1989; 28:7453-7461.
32. Rauch J, Janoff AS. The nature of antiphospholipid antibodies. J Rheumatol 1992; 19:1782-1785.
33. Smirnov MD, Esmon CT. Phosphatidylethanolamine incorporation into vesicles selectively enhances factor Va inactivation by activated protein C. J Biol Chem 1994; 269:816-819.
34. Neuenschwander PF, Bianco-Fisher E, Rezaie AR, Morrissey JH. Phosphatidylethanolamine augments factor VIIa-tissue factor activity: Enhancement of sensitivity to phosphatidylserine. Biochemistry 1995; 34:13988-13993.
35. Bevers EM, Comfurius P, Zwaal RFA. Changes in membrane phospholipid distribution during platelet activation. Biochim Biophys Acta 1983; 736:57-66.
36. Nakagaki T, Foster DC, Berkner KL, Kisiel W. Initiation of the extrinsic pathway of blood coagulation: Evidence for the tissue factor dependent autoactivation of human coagulation factor VII. Biochemistry 1991; 30:10819-10824.
37. Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-co-factor and zymogen-cof actor complexes. Implications of a two-dimensional enzyme kinetic mechanism. J Biol Chem 1993; 268:21489-21492.
38. Fiore MM, Neuenschwander PF, Morrissey JH. The biochemical basis for the apparent defect of soluble mutant tissue factor in enhancing the proteolytic activities of factor VIIa. J Biol Chem 1994; 269:143-149.
39. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81:734-744.
40. Morrissey JH. Tissue factor modulation of factor VIIa activity: Use in measuring trace levels of factor VIIa in plasma. Thromb Haemost 1995; 74:185-188.
41. Nelsestuen GL, Kisiel W, Di Scipio RG. Interaction of vitamin K dependent proteins with membranes. Biochemistry 1978; 172134-2138.
42. a in tissue factor interactions. FEBS Lett 1994; 347:73-79.
43. Martin DMA, O'Brien DP, Tuddenham EGD, Byfield PGH. Synthesis and characterization of wild-type and variant gamma-carboxyglutamic acid-containing domains of factor VII. Biochemistry 1993; 32:13949-13955.
44. Rezaie AR, Neuenschwander PF, Morrissey JH, Esmon CT. Analysis of the functions of the first epidermal growth factor-like domain of factor X. J Biol Chem 1993; 268:8176-8180.
45. Roy S, Hass PE, Bourell JH, Henzel WJ, Vehar GA. Lysine residues 165 and 166 are essential for the cofactor function of tissue factor. J Biol Chem 1991; 266:22063-22066.
46. Ruf W, Miles DJ, Rehemtulla A, Edgington TS. Cofactor residues lysine 165 and 166 are critical for protein substrate recognition by the tissue factor-factor VIIa protease complex. J Biol Chem 1992; 267:6375-6381.
47. 166 of tissue factor with the 4-carboxyglutamate-rich domain of factor X. J Biol Chem 1996; 271:21752-21757.